These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 26726766)

  • 41. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study.
    Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T
    BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stimulants for impulsive violence in schizophrenia spectrum disordered women: a case series and brief review.
    Skoretz P; Tang C
    CNS Spectr; 2016 Dec; 21(6):445-449. PubMed ID: 27181114
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in psychopharmacotherapy for patients with schizophrenia in a psychiatric institution in Japan: A 12-year prescription survey pre- and post-introduction of clozapine.
    Kitagawa K; Uekusa S; Hanai Y; Kimura I; Tsukahara M; Kagawa A; Sasaoka K; Sakishiro Y; Miyake A; Watanabe Y; Baba D; Kodama M; Kishi Y; Yamada N; Yoshio T; Matsuo K
    Asian J Psychiatr; 2024 Jun; 96():104047. PubMed ID: 38640549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardio-metabolic risk and its management in a cohort of clozapine-treated outpatients.
    Lappin JM; Wijaya M; Watkins A; Morell R; Teasdale S; Lederman O; Rosenbaum S; Dick S; Ward P; Curtis J
    Schizophr Res; 2018 Sep; 199():367-373. PubMed ID: 29486959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ethnic comparisons of antipsychotic use in schizophrenia.
    Wheeler A; Humberstone V; Robinson E
    Aust N Z J Psychiatry; 2008 Oct; 42(10):863-73. PubMed ID: 18777230
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.
    Ganguly R; Kotzan JA; Miller LS; Kennedy K; Martin BC
    J Clin Psychiatry; 2004 Oct; 65(10):1377-88. PubMed ID: 15491242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clozapine in Reducing Aggression and Violence in Forensic Populations.
    Patchan K; Vyas G; Hackman AL; Mackowick M; Richardson CM; Love RC; Wonodi I; Sayer MA; Glassman M; Feldman S; Kelly DL
    Psychiatr Q; 2018 Mar; 89(1):157-168. PubMed ID: 28643049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.
    Lamberti JS; Costea GO; Olson D; Crilly JF; Maharaj K; Tu X; Groman A; Dietz MB; Bushey MP; Olivares T; Wiener K
    J Clin Psychiatry; 2005 Jul; 66(7):900-6. PubMed ID: 16013906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trends in and Predictors of Long-Term Antipsychotic Polypharmacy Use Among Ohio Medicaid Patients with Schizophrenia, 2008-2014.
    Fontanella CA; Hiance-Steelesmith DL; Guirgis H; Campo JV
    Psychiatr Serv; 2018 Sep; 69(9):1015-1020. PubMed ID: 29962308
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clozapine use in a forensic population in a New South Wales prison hospital.
    Martin A; O'Driscoll C; Samuels A
    Aust N Z J Psychiatry; 2008 Feb; 42(2):141-6. PubMed ID: 18197509
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Geographic and clinical variation in clozapine use in the United States.
    Stroup TS; Gerhard T; Crystal S; Huang C; Olfson M
    Psychiatr Serv; 2014 Feb; 65(2):186-92. PubMed ID: 24233347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Frequency and correlates of antipsychotic polypharmacy among patients with schizophrenia in Denmark: A nation-wide pharmacoepidemiological study.
    Sneider B; Pristed SG; Correll CU; Nielsen J
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1669-76. PubMed ID: 26256007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Underprescribing of clozapine and unexplained variation in use across hospitals and regions in the Canadian province of Québec.
    Latimer E; Wynant W; Clark R; Malla A; Moodie E; Tamblyn R; Naidu A
    Clin Schizophr Relat Psychoses; 2013 Apr; 7(1):33-41. PubMed ID: 23367500
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of clozapine on aggression and substance abuse in schizophrenic patients.
    Volavka J
    J Clin Psychiatry; 1999; 60 Suppl 12():43-6. PubMed ID: 10372611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study.
    Solmi M; Tiihonen J; Lähteenvuo M; Tanskanen A; Correll CU; Taipale H
    Schizophr Bull; 2022 Jan; 48(1):166-175. PubMed ID: 34286338
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does clozapine promote employability and reduce offending among mentally disordered offenders?
    Balbuena L; Mela M; Wong S; Gu D; Adelugba O; Tempier R
    Can J Psychiatry; 2010 Jan; 55(1):50-6. PubMed ID: 20113544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prescribing patterns for inpatients with schizophrenia spectrum disorders in a psychiatric hospital in Slovenia: Results of 16-month prospective, non-interventional clinical research.
    Bole CB; Pišlar M; Mrhar A; Tavčar R
    Psychiatr Danub; 2017 Jun; 29(2):155-161. PubMed ID: 28636573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study.
    Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L
    Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.